Viewing Study NCT02585895

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:59 PM
Ignite Modification Date: 2026-02-21 @ 3:45 AM
Study NCT ID: NCT02585895
Status: COMPLETED
Last Update Posted: 2022-11-30
First Post: 2015-10-07
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Evolocumab Compared to LDL-C Apheresis in Patients Receiving LDL-C Apheresis Prior to Study Enrollment
Sponsor: Amgen
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hypercholesterolemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None LDL-C Apheresis View
None Hypercholesterolemia View
None Elevated Cholesterol View
None High Cholesterol View
None PCSK9 mutations View
None Severe Familial Hypercholesterolemia View
None evolocumab View
None Repatha View